Atrial Fibrillation in Advanced Chronic Kidney Disease: To Anticoagulate or Not, and With What? @UCSFDepartmentofMedicine
Atrial Fibrillation in Advanced Chronic Kidney Disease: To Anticoagulate or Not, and With What?  @UCSFDepartmentofMedicine
Uploaded June 2026 | Updated November 2026, 3 hours ago
The Gary Kardos Visiting Professor Lecture

Atrial fibrillation affects many patients with advanced chronic kidney disease (CKD), but the optimal approach to anticoagulation remains uncertain. For our annual Kardos Medical Grand Rounds, Wolfgang C. Winkelmayer, chief of the Section of Nephrology at Baylor College of Medicine, will examine strategies for stroke prevention in patients with advanced CKD and atrial fibrillation, highlighting the challenges of extrapolating findings from the general population. The lecture will review emerging data and practical considerations to help clinicians navigate anticoagulation decisions in this complex and high-risk population.

This lecture is held in memory of Gary Kardos, an esteemed UCSF clinician-educator and nephrologist who served the institution for several decades.

Speaker:
Wolfgang C. Winkelmayer, MD, MPH, ScD, is the Gordon A. Cain Chair in Nephrology, a professor of medicine, and chief of the Section of Nephrology at Baylor College of Medicine. He previously served as director of clinical research in the Division of Nephrology at Stanford University and as a professor of medicine at Brigham and Women's Hospital and Harvard Medical School. Winkelmayer is a former co-chair of Kidney Disease: Improving Global Outcomes (KDIGO), served as an associate editor of JAMA for 15 years, and is the incoming editor-in-chief of the American Journal of Kidney Diseases.

Program:
Bob Wachter, MD: Introduction
2:45-44:50 — Wolfgang C. Winkelmayer, MD, MPH, ScD
44:50-55:16 — Q&A

See previous Medical Grand Rounds:

May 26: Innovations in the Diagnosis and Treatment of Chronic Kidney Disease
• youtu.be/3usj-GT7RZQ
May 19: Updated Thyroid Cancer Guidelines: Personalized Approaches for Optimized Care
• youtu.be/fVMBeypS5x4
May 14: Lead from Where You Stand: How to Advocate forYour Patients, Your Profession, and Yourself
• youtu.be/tuNR8Rc3ygc
May 5: Hollander Rounds: A Clinical Problem-Solving Case
• youtu.be/v5OObq-Ocp4
Atrial Fibrillation in Advanced Chronic Kidney Disease: To Anticoagulate or Not, and With What?A Conversation with FDA Commissioner Robert CaliffMultimodal Treatment of Obesity: Lifestyle Interventions, Medications, & Bariatric SurgeryPancreatic Cancer in 2026: The Dawn of a New Era?Clinical Problem Solving with Lisa WinstonLifestyle and Atrial Fibrillation: Adventures in Clinical ResearchIs the End of the Tobacco Epidemic Within Reach?Covid-19 in 2023: A Conversation with White House Covid Coordinator Ashish JhaProtecting the Legitimacy of Medical Expertise: Combating Misinformation in MedicineUCSF Department of Medicine Internal Medicine Residency Program: UCPC/SFPC Tracks 2021-22Leadership 201: Lessons Learned from Leading Through Pandemics and Political PartisanshipImplications of the 2024 Election on Health Policy
UCSF Department of Medicine |

Atrial Fibrillation in Advanced Chronic Kidney Disease: To Anticoagulate or Not, and With What?

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER